Miniatura

Fitxers

682703.pdf (445.64 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2018-05-03

Llicència de publicació

cc-by (c) Jarius, S. et al., 2018
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/133483

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1186/s12974-018-1144-2

Resum

Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brainstem encephalitis, as well as with acute disseminated encephalomyelitis (ADEM)-like presentations. Most experts now consider MOG-IgG-associated encephalomyelitis (MOG-EM) a disease entity in its own right, immunopathogenetically distinct from both classic multiple sclerosis (MS) and aquaporin-4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorders (NMOSD). Owing to a substantial overlap in clinicoradiological presentation, MOG-EM was often unwittingly misdiagnosed as MS in the past. Accordingly, increasing numbers of patients with suspected or established MS are currently being tested for MOG-IgG. However, screening of large unselected cohorts for rare biomarkers can significantly reduce the positive predictive value of a test. To lessen the hazard of overdiagnosing MOG-EM, which may lead to inappropriate treatment, more selective criteria for MOG-IgG testing are urgently needed. In this paper, we propose indications for MOG-IgG testing based on expert consensus. In addition, we give a list of conditions atypical for MOG-EM ('red flags') that should prompt physicians to challenge a positive MOG-IgG test result. Finally, we provide recommendations regarding assay methodology, specimen sampling and data interpretation.

Matèries

Diagnòstic, Esclerosi múltiple, Mielitis, Malalties del sistema nerviós central

Matèries (anglès)

Diagnosis, Multiple sclerosis, Myelitis, Central nervous system diseases

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

JARIUS, S., PAUL, F., AKTAS, Orhan, ASGARI, Nasrin, DALE, Russell c., SEZE, J. de, FRANCIOTTA, Diego, FUJIHARA, Kazuo, JACOB, Anu, KIM, H. j., KLEITER, Ingo, KÜMPFEL, Tania, LEVY, Michael, PALACE, Jacqueline, RUPRECHT, Klemens, SAIZ HINAREJOS, Albert, TREBST, Corinna, WEINSHENKER, Brian g., WILDEMANN, Brigitte. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. _Journal of Neuroinflammation_. 2018. Vol. 15, núm. 1. [consulta: 20 de gener de 2026]. ISSN: 1742-2094. [Disponible a: https://hdl.handle.net/2445/133483]

Exportar metadades

JSON - METS

Compartir registre